Edition:
India

AxoGen Inc (AXGN.OQ)

AXGN.OQ on NASDAQ Stock Exchange Capital Market

10.81USD
5 Jun 2020
Change (% chg)

$0.79 (+7.88%)
Prev Close
$10.02
Open
$10.34
Day's High
$10.97
Day's Low
$10.34
Volume
262,574
Avg. Vol
162,290
52-wk High
$22.91
52-wk Low
$7.16

Latest Key Developments (Source: Significant Developments)

Axogen Inc Sees Q1 Revenue About $24.3 Mln
Thursday, 23 Apr 2020 

April 23 (Reuters) - AxoGen Inc ::AXOGEN, INC. REPORTS PRELIMINARY REVENUE FOR THE FIRST QUARTER 2020, PROVIDES BUSINESS UPDATE IN RESPONSE TO COVID-19 PANDEMIC, AND ANNOUNCES DISMISSAL OF CLASS ACTION LAWSUIT.SEES Q1 2020 REVENUE ABOUT $24.3 MILLION.SAYS IMPLEMENTED PLAN REDUCING EXECUTIVE CASH COMPENSATION AND BOARD FEES BY 20%.SAYS PLAN INCLUDES REDUCING CASH COMPENSATION FOR ALL OTHER EMPLOYEES BY 10% TO 15%.SAYS COMPLETED EMPLOYEE LAYOFF OF APPROXIMATELY 10% OF ITS WORKFORCE AND IMPLEMENTED A HIRING FREEZE.  Full Article

Axogen Posts Quarterly Adjusted Loss Per Share Of $0.10
Tuesday, 25 Feb 2020 

Feb 24 (Reuters) - AxoGen Inc ::AXOGEN, INC. REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS.Q4 ADJUSTED LOSS PER SHARE $0.10.Q4 LOSS PER SHARE $0.18.Q4 SALES $28.1 MILLION.SEES FY 2020 REVENUE $124 MILLION TO $128 MILLION.EXPECTS THAT NUMBER OF DIRECT SALES REPRESENTATIVES WILL INCREASE TO BETWEEN APPROXIMATELY 126 AND 131 IN 2020.EXPECTS GROSS MARGIN TO REMAIN ABOVE 80% AND OPERATING MARGIN WILL SEE MODERATE IMPROVEMENT YEAR OVER YEAR IN 2020.FY2020 REVENUE VIEW $131.7 MILLION -- REFINITIV IBES DATA.  Full Article

AxoGen, Inc. Reports 2019 Third Quarter Financial Results
Thursday, 7 Nov 2019 

Nov 6 (Reuters) - AxoGen Inc ::AXOGEN, INC. REPORTS 2019 THIRD QUARTER FINANCIAL RESULTS.Q3 ADJUSTED LOSS PER SHARE $0.07.Q3 LOSS PER SHARE $0.14.Q3 SALES $28.6 MILLION.SEES FY 2019 REVENUE $106 MILLION TO $110 MILLION.SAYS REITERATES ITS 2019 EXPECTATION FOR GROSS MARGIN TO REMAIN ABOVE 80%.  Full Article

Axogen Inc Reports Q2 2019 Results
Wednesday, 7 Aug 2019 

Aug 6 (Reuters) - AxoGen Inc ::AXOGEN, INC. REPORTS 2019 SECOND QUARTER FINANCIAL RESULTS.Q2 ADJUSTED LOSS PER SHARE $0.10.Q2 LOSS PER SHARE $0.18.Q2 REVENUE ROSE 30 PERCENT TO $26.7 MILLION.SEES FY 2019 REVENUE ABOUT $106 MILLION TO $110 MILLION.REITERATES ITS EXPECTATION FOR GROSS MARGIN TO REMAIN ABOVE 80% FOR 2019.  Full Article

Axogen Reports Q1 Loss Per Share $0.24
Thursday, 9 May 2019 

May 8 (Reuters) - AxoGen Inc ::AXOGEN, INC. REPORTS 2019 FIRST QUARTER FINANCIAL RESULTS.Q1 ADJUSTED LOSS PER SHARE $0.15.Q1 LOSS PER SHARE $0.24.Q1 REVENUE ROSE 35 PERCENT TO $23.3 MILLION.SEES FY 2019 REVENUE $109 MILLION TO $114 MILLION.ENDED QUARTER WITH $113.8 MILLION IN CASH, CASH EQUIVALENTS, AND INVESTMENTS COMPARED TO $122.6 MILLION AT END OF Q4 OF 2018.Q1 EARNINGS PER SHARE VIEW $-0.13, REVENUE VIEW $22.3 MILLION -- REFINITIV IBES DATA.FY2019 REVENUE VIEW $111.4 MILLION -- REFINITIV IBES DATA.  Full Article

AxoGen Sees FY 2019 Revenue Up At Least 35 Pct
Monday, 7 Jan 2019 

Jan 7 (Reuters) - AxoGen Inc ::SEES Q4 REVENUE AT LEAST $23.4 MILLION.SEES FY 2019 REVENUE UP AT LEAST 35 PERCENT.SEES FY 2018 REVENUE AT LEAST $83.9 MILLION.Q4 REVENUE ROSE 38 PERCENT TO $23.4 MILLION.COMPANY REAFFIRMS 2019 FINANCIAL GUIDANCE AND PROVIDES BUSINESS UPDATE.FY2018 REVENUE VIEW $84.6 MILLION -- REFINITIV IBES DATA.  Full Article

BRIEF-Axogen Appoints Brad Ottinger As General Counsel, Chief Compliance Officer

* AXOGEN, INC. ANNOUNCES PLANNED RETIREMENT OF GREG FREITAG AND APPOINTS BRAD OTTINGER AS GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER Source text for Eikon: Further company coverage: